Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Why not treat human cancer with interleukin-1 blockade?
2010
Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet
2003 Standout
Ecological effects, transport, and fate of mercury: a general review
2000 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Signal Transduction by the JNK Group of MAP Kinases
2000 Standout
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
2000
Mechanistic Aspects of Inflammation and Clinical Management of Inflammation in Acute Gouty Arthritis
2013
MAP kinase signalling pathways in cancer
2007 Standout
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Gout
2016 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Hidradenitis suppurativa
2020 Standout
Mechanisms and Functions of Inflammasomes
2014 Standout
Rilonacept (interleukin‐1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double‐blind, placebo‐controlled, confirmatory efficacy study
2012
Embryotoxicity and dose-response relationships of selenium in hamsters
1990
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
2012
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
2001 Standout
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Gout
2021 Standout
Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial
2018
Embryonic susceptibility of Microtus ochrogaster (common prairie vole) to phenyl mercuric acetate
1976
Works of K Huston being referenced
IL-1 Inhibition With Anakinra in a Patient With Refractory Gout
2009
Congenital syndrome in Hereford calves with kyphoscoliosis, arthrogryposis and palatoschisis.
1974
The development of bovine syndactylism
1968
Three Mutations and the Karyotype of the Prairie Vole
1974